<p>Schrödinger（納斯達克代碼：SDGR - 獲取免費報告）預計將在 2 月 26 日星期三市場收盤後公佈其財報。分析師預計該公司每股收益為（$0.35），季度收入為 8320 萬美元。對參與公司電話會議感興趣的投資者可以使用此鏈接。</p>
<h2>Schrödinger 股價表現</h2>
<ul>
<li>AI 製藥：通往 AI 驅動藥物投資的兩條路徑</li>
</ul>
<p>納斯達克 SDGR 的股票週一開盤價為 22.64 美元。該公司的市值為 16.5 億美元，市盈率為-9.68，貝塔值為 1.61。該公司的 50 日移動平均價格為 22.19 美元，200 日移動平均價格為 20.52 美元。Schrödinger 的 52 周低點為 16.67 美元，52 周高點為 33.63 美元。</p>
<h2>分析師評級上調與下調</h2>
<p>多家研究公司最近對 SDGR 發表了評論。BMO 資本市場將 Schrödinger 的目標價從 25.00 美元上調至 28.00 美元，並在 11 月 13 日的報告中給予該股票 “跑贏大盤” 的評級。KeyCorp 將 Schrödinger 的目標價從 25.00 美元上調至 27.00 美元，並在 1 月 24 日的報告中給予該股票 “增持” 的評級。三位投資分析師對該股票給予持有評級，六位給予買入評級，一位給予強烈買入評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 32.11 美元。</p>
<ul>
<li>儘管每股收益超預期，Simulations Plus 股票下跌 15%</li>
</ul>
<p><strong>查看我們關於 Schrödinger 的最新研究報告</strong></p>
<h2>關於 Schrödinger</h2>
<p>（獲取免費報告）</p>
<p>Schrödinger, Inc 及其子公司開發基於物理的計算平台，能夠發現用於藥物開發和材料應用的新分子。該公司分為兩個部門，軟件和藥物發現。軟件部門專注於將其軟件授權給生命科學和材料科學行業，以轉變分子發現。</p>
<h2>精選故事</h2>
<ul>
<li>我們更看好的五隻股票超過 Schrödinger</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>為什麼 Genuine Parts Company 現在是一個非常好的買入機會</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克何時關閉</li>
<li>工業股悄然超越市場：3 只值得關注的股票</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>這 5 只能源股以增長潛力對沖通脹</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg"/></p>
<ul>
<li>這裏有 3 只 AI 藥物發現股票值得你關注</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Schrödinger 嗎？</h2>
<p>在你考慮 Schrödinger 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Schrödinger 並不在名單上。</p>
<p>雖然 Schrödinger 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

SDGR

<p>Schrodinger（納斯達克代碼：SDGR）將於 2 月 26 日公佈財報，預計每股虧損 0.35 美元，收入為 8320 萬美元。該股開盤價為 22.64 美元，市值為 16.5 億美元。分析師的共識評級為 “適度買入”，目標價為 32.11 美元。最近的升級包括 BMO 資本市場將目標價從 25 美元上調至 28 美元，以及 KeyCorp 將目標價從 25 美元上調至 27 美元。投資者可以通過提供的鏈接加入電話會議</p>

<p>Schrödinger (NASDAQ:SDGR - Get Free Report) is anticipated to announce its earnings results after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $83.20 million for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.</p>
<div class="lb-trans"><p>Schrödinger（納斯達克代碼：SDGR - 獲取免費報告）預計將在 2 月 26 日星期三市場收盤後公佈其財報。分析師預計該公司每股收益為（$0.35），季度收入為 8320 萬美元。對參與公司電話會議感興趣的投資者可以使用此鏈接。</p>
</div><h2>Schrödinger Price Performance</h2>
<div class="lb-trans"><h2>Schrödinger 股價表現</h2>
</div><ul>
<li>AI Pharma: 2 Paths to AI-Powered Drug Investment</li>
</ul>
<div class="lb-trans"><ul>
<li>AI 製藥：通往 AI 驅動藥物投資的兩條路徑</li>
</ul>
</div><p>Shares of NASDAQ SDGR opened at $22.64 on Monday. The stock has a market capitalization of $1.65 billion, a PE ratio of -9.68 and a beta of 1.61. The business has a fifty day moving average price of $22.19 and a two-hundred day moving average price of $20.52. Schrödinger has a fifty-two week low of $16.67 and a fifty-two week high of $33.63.</p>
<div class="lb-trans"><p>納斯達克 SDGR 的股票週一開盤價為 22.64 美元。該公司的市值為 16.5 億美元，市盈率為-9.68，貝塔值為 1.61。該公司的 50 日移動平均價格為 22.19 美元，200 日移動平均價格為 20.52 美元。Schrödinger 的 52 周低點為 16.67 美元，52 周高點為 33.63 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><p>A number of research firms have recently commented on SDGR. BMO Capital Markets boosted their price target on Schrödinger from $25.00 to $28.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, November 13th. KeyCorp boosted their price target on Schrödinger from $25.00 to $27.00 and gave the stock an &#34;overweight&#34; rating in a report on Friday, January 24th. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $32.11.</p>
<div class="lb-trans"><p>多家研究公司最近對 SDGR 發表了評論。BMO 資本市場將 Schrödinger 的目標價從 25.00 美元上調至 28.00 美元，並在 11 月 13 日的報告中給予該股票 “跑贏大盤” 的評級。KeyCorp 將 Schrödinger 的目標價從 25.00 美元上調至 27.00 美元，並在 1 月 24 日的報告中給予該股票 “增持” 的評級。三位投資分析師對該股票給予持有評級，六位給予買入評級，一位給予強烈買入評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，共識目標價為 32.11 美元。</p>
</div><ul>
<li>Simulations Plus Stock Drops 15% Despite EPS Beat</li>
</ul>
<div class="lb-trans"><ul>
<li>儘管每股收益超預期，Simulations Plus 股票下跌 15%</li>
</ul>
</div><p><strong>View Our Latest Research Report on Schrödinger</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Schrödinger 的最新研究報告</strong></p>
</div><h2>About Schrödinger</h2>
<div class="lb-trans"><h2>關於 Schrödinger</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.</p>
<div class="lb-trans"><p>Schrödinger, Inc 及其子公司開發基於物理的計算平台，能夠發現用於藥物開發和材料應用的新分子。該公司分為兩個部門，軟件和藥物發現。軟件部門專注於將其軟件授權給生命科學和材料科學行業，以轉變分子發現。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Schrödinger</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Why Genuine Parts Company Is a Royally Good Buy Right Now</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>These 5 Energy Stocks Hedge Inflation With Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Schrödinger</li>
<li>每股收益計算器：如何計算 EPS</li>
<li>為什麼 Genuine Parts Company 現在是一個非常好的買入機會</li>
<li>2022-2025 年股市假期 - 紐約證券交易所和納斯達克何時關閉</li>
<li>工業股悄然超越市場：3 只值得關注的股票</li>
<li>澳大利亞證券交易所（ASX）是什麼</li>
<li>這 5 只能源股以增長潛力對沖通脹</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0RHUg" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=SDGR"/></p>
<ul>
<li>Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist</li>
</ul>
<div class="lb-trans"><ul>
<li>這裏有 3 只 AI 藥物發現股票值得你關注</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Schrödinger Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Schrödinger 嗎？</h2>
</div><p>Before you consider Schrödinger, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Schrödinger 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前買入……而 Schrödinger 並不在名單上。</p>
</div><p>While Schrödinger currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Schrödinger 目前在分析師中獲得 “適度買入” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Schrödinger (SDGR) 預計將在週三發佈財報